Click image to zoom

Pfizer Receives Health Canada Authorization For COVID-19 Oral Treatment

An illustrative image of a medical tablet seen in front of the Pfizer-logo. On Wednesday, January 19, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto)

Photo Details

Photo ID	#7658210
Date Taken	19 January 2022
Location	N/A
Photographer	Artur Widak/NurPhoto
Category	Stock Photos
Copyright	© 2026 NurPhoto - Artur Widak/NurPhoto

Related Keywords

2022 Agreement Authorized Business Finance and Industry COVID-19 COVID-19 tablets Canada Communication Coronavirus Delivery Economy Essential Services Europe Finance and Economy Government of Canada Health Canada Healthcare And Medicine Illness Infectious Disease Lifestyles Medical Research PAXLOVID Pandemic - Illness Pfizer Pfizer Canada SARS-CoV-2 Mpro SARS-CoV-2 Omicron Variant Science and Technology Virus Organism Winter blocking dose high-risk adults hospitalization illustration impact lockdown medecine nirmatrelvir nirmatrelvir tablets oral treatment preparation ritonavir tablets rules severe COVID-19 showing start supply technology treatment use illustrative image medical tablet front Pfizer-logo Wednesday January Edmonton Alberta Canada Photo

License This Photo

Digital Basic Editorial use on digital platforms only (websites, social media). Single use, up to 1 million monthly UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€35.00

Editorial Print & Digital For editorial use in print and digital publications such as newspapers, magazines, and textbooks. Single use, up to 10,000 copies or 1 million UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€99.00

Broadcast (TV & Digital) For editorial use in TV production or streaming platforms. Single use, all media rights excluding theatrical, with worldwide distribution in perpetuity. NO COMMERCIAL OR PROMOTIONAL USE

€399.00

Total Price

€35.00

Secure checkout

Need a custom license?

Contact Sales